Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viral Shedding of LAIV in Children
NCT03735147Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Oct 2018
- Primary completion
- Apr 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of live attenuated influenza vaccine in influenza, sponsored by Imperial College London. Primary endpoint: Type-specific Vaccine Virus Shedding at Day 8. Started Oct 2018; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03735147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03735147.